Oncology Clinical Trial
Official title:
Evaluation Der Telerehabilitation im Anschluss an Eine stationäre Oder Ambulante Rehabilitation Phase II - Pilotprojekt [Evaluation of Telerehabilitation Following Inpatient or Outpatient Rehabilitation Phase II - Pilot Project]
Verified date | July 2022 |
Source | Pensionsversicherungsanstalt |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Telerehabilitation is implemented in the Pensionsversicherungsanstalt (PVA) as an independent rehabilitation offer following a rehabilitation phase II. This offer primarily includes physiotherapeutic training units in group settings and in individual counselling, as well as health-related educational sessions and doctor's consultations via video conferencing, initially for rehabilitation patients with diseases of the musculoskeletal system or oncological diseases. The first stage of the implementation process was evaluated with a focus on acceptance, usability and feasibility from the perspective of patients and treatment team. The evaluation was based on a convergent mixed methods design (Creswell & Plano Clark, 2017) to draw on the strengths of qualitative and quantitative research approaches (Creswell & Creswell, 2018). Qualitative and quantitative data were generated in parallel and treated equally. The perspective of the patients (N = 86) was collected through online questionnaires and in-depth telephone interviews (N = 22) and that of the treatment team through a questionnaire survey (N = 32) and focus group interviews (N = 24). The administrative team (N = 8) was asked for their assessment in a focus group interview. Technical difficulties in the implementation of telerehabilitation were documented by the treatment team. The consolidation of these multi-perspective results took place at the level of interpretation.
Status | Completed |
Enrollment | 126 |
Est. completion date | June 30, 2022 |
Est. primary completion date | March 31, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: Patients who have completed rehabilitation (phase II) with the indications: - musculoskeletal diseases - oncology. Exclusion Criteria: - Failure to obtain the declaration of consent - Lack of the required technical aids (mobile phone, tablet or PC) - Lack of the technical skills to operate the app and thus to participate in telerehabilitation. |
Country | Name | City | State |
---|---|---|---|
Austria | PVA - Zentrum für ambulante Rehabilitation Graz | Graz | Styria |
Lead Sponsor | Collaborator |
---|---|
Pensionsversicherungsanstalt |
Austria,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Usability of the telerehabilitation | The patients' perspective was collected with a self-developed online questionnaire (N = 86) and in-depth telephone interviews (N = 22).
The questionnaires were analysed descriptively. The telephone interviews were protocolled and subsequently coded and categorised. The perspective of the treatment team was collected with a self-developed questionnaire (N = 32) and focus group interviews (N = 24). In addition, the administrative team (N = 8) was asked for their assessments in a focus group interview. The questionnaires were analysed descriptively. The focus group interview was recorded and subsequently coded and categorised. |
April 2021 - May 2022 | |
Primary | Feasibility of the telerehabilitation | Technical difficulties concerning the video calls were continuously documented by the treatment team. The data were analysed descriptively. | April 2021 - May 2022 | |
Primary | Acceptance of the telerehabilitation | The patients' perspective was collected with a self-developed online questionnaire (N = 86) and in-depth telephone interviews (N = 22).
The questionnaires were analysed descriptively. The telephone interviews were protocolled and subsequently coded and categorised. The perspective of the treatment team was collected with a self-developed questionnaire (N = 32) and focus group interviews (N = 24). The questionnaires were analysed descriptively. The focus group interviews were recorded and subsequently coded and categorised. |
April 2021 - May 2022 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01439152 -
Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors.
|
Phase 1 | |
Recruiting |
NCT05615246 -
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
|
||
Active, not recruiting |
NCT06015009 -
Symptom Management App for Children at the Early Stage of Cancer Survivorship and Their Caregivers
|
N/A | |
Active, not recruiting |
NCT03298100 -
Risk Scoring Model for Endometrial Cancer
|
||
Recruiting |
NCT05055609 -
Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors
|
Phase 1 | |
Not yet recruiting |
NCT04324320 -
Psychological Distress in Outpatient Oncological Rehabilitation
|
||
Completed |
NCT00588289 -
Long Term Follow-Up of Patients on Children's Cancer Group Protocols- (CCG-LTF1) FOLLOW-UP DATA
|
N/A | |
Recruiting |
NCT06222801 -
The 1st Tumor CytokinoTherapy Database (TCTD-1)
|
||
Recruiting |
NCT03831633 -
Comparative Effectiveness of AKYNZEO® and Standard of Care (Including EMEND®) for the Prevention of Nausea and Vomiting (CINV) in Cancer Patients
|
Phase 4 | |
Completed |
NCT04914702 -
Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer.
|
||
Recruiting |
NCT05198570 -
Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients
|
||
Recruiting |
NCT05712174 -
A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT03832062 -
Value of Analysing Under-utilised Leftover Tissue (VauLT)
|
||
Completed |
NCT03988777 -
Magnetic Seed Localisation for Nonpalpable Breast Lesions
|
||
Recruiting |
NCT06031233 -
Evaluating the Safety of Shortened Infusion Times for dIfferent Oncological Immunotherapie
|
Phase 4 | |
Enrolling by invitation |
NCT04019119 -
Digital Intervention for the Modification of Lifestyles (iGame)
|
N/A | |
Not yet recruiting |
NCT05926362 -
Capillary-Venous Paired Data Collection
|
||
Recruiting |
NCT05686213 -
ExeNTrO: Exercise During Neoadjuvant Chemoradiation Treatment to Improve Rectal and Esophageal Cancer Outcome - Pilot Trial
|
Phase 2 | |
Recruiting |
NCT05510856 -
Comparative Clinical Study Evaluating the Possible Efficacy of Duloxetine, Gabapentin and Lacosamide on Oxaliplatin-Induced Peripheral Neuropathy in Cancer Patients
|
Phase 4 | |
Completed |
NCT04180306 -
PEWS Implementation in an LMIC Setting
|
N/A |